• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因多态性可作为肺癌的危险因素:来自亚马逊地区患者的初步研究。

Gene Polymorphism Contributes as a Risk Factor for Lung Cancer: A Pilot Study with Patients from the Amazon.

机构信息

Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belem 66077-830, Brazil.

Oncology Research Center, Federal University of Pará, Belem 66073-005, Brazil.

出版信息

Genes (Basel). 2022 Mar 11;13(3):493. doi: 10.3390/genes13030493.

DOI:10.3390/genes13030493
PMID:35328047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954358/
Abstract

Lung cancer is one of the most frequent neoplasms in the world. Because it is a complex disease, its formation occurs in several stages, stemming from interactions between environmental risk factors, such as smoking, and individual genetic susceptibility. Our objective was to investigate associations between a gene polymorphism (rs8175347) and lung cancer risk in an Amazonian population. This is a pilot study, case-controlled study, which included 276 individuals with cancer and without cancer. The samples were analyzed for polymorphisms of the gene (rs8175347) and genotyped in PCR, followed by fragment analysis in which we applied a previously developed set of informative ancestral markers. We used logistic regression to identify differences in allelic and genotypic frequencies between individuals. Individuals with the TA7 allele have an increased chance of developing lung adenocarcinoma ( = 0.035; OR: 2.57), as well as those with related genotypes of reduced or low enzymatic activity: TA6/7, TA5/7, and TA7/7 ( = 0.048; OR: 8.41). Individuals with homozygous TA7/7 have an increased chance of developing squamous cell carcinoma of the lung ( = 0.015; OR: 4.08). Polymorphism in the gene (rs8175347) may contribute as a risk factor for adenocarcinoma and lung squamous cell carcinoma in the population of the Amazon region.

摘要

肺癌是世界上最常见的肿瘤之一。由于它是一种复杂的疾病,其形成发生在几个阶段,源于环境风险因素(如吸烟)与个体遗传易感性之间的相互作用。我们的目的是研究亚马逊地区人群中一个基因多态性(rs8175347)与肺癌风险之间的关联。这是一项病例对照的初步研究,共纳入了 276 名癌症患者和非癌症患者。对基因(rs8175347)的多态性进行了分析,并在 PCR 中进行了基因分型,随后进行了片段分析,应用了先前开发的一套信息性祖先标记。我们使用逻辑回归来识别个体间等位基因和基因型频率的差异。携带 TA7 等位基因的个体发生肺腺癌的几率增加(=0.035;OR:2.57),而相关的低或低酶活性基因型 TA6/7、TA5/7 和 TA7/7 也是如此(=0.048;OR:8.41)。纯合 TA7/7 的个体发生肺鳞状细胞癌的几率增加(=0.015;OR:4.08)。基因(rs8175347)的多态性可能是亚马逊地区人群中腺癌和肺鳞状细胞癌的一个危险因素。

相似文献

1
Gene Polymorphism Contributes as a Risk Factor for Lung Cancer: A Pilot Study with Patients from the Amazon.基因多态性可作为肺癌的危险因素:来自亚马逊地区患者的初步研究。
Genes (Basel). 2022 Mar 11;13(3):493. doi: 10.3390/genes13030493.
2
Pazopanib-Induced Liver Toxicity in Patients With Metastatic Renal Cell Carcinoma: Effect of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety, and Patient Outcomes.帕唑帕尼诱导的转移性肾细胞癌患者的肝毒性:UGT1A1 多态性对帕唑帕尼剂量调整、安全性和患者结局的影响。
Clin Genitourin Cancer. 2020 Feb;18(1):62-68.e2. doi: 10.1016/j.clgc.2019.09.013. Epub 2019 Sep 26.
3
[Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)].[尿苷二磷酸葡萄糖醛酸基转移酶1A1(UGT1A1)基因多态性与伊立替康联合S-1治疗复发或转移性食管鳞状细胞癌患者不良事件的相关性:一项前瞻性、开放标签、随机对照试验(ESWN 01)]
Zhonghua Zhong Liu Za Zhi. 2021 Nov 23;43(11):1177-1182. doi: 10.3760/cma.j.cn112152-20191022-00678.
4
UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.UGT1A1 预测伊立替康和氟尿嘧啶治疗结直肠癌的疗效。
World J Gastroenterol. 2012 Dec 7;18(45):6635-44. doi: 10.3748/wjg.v18.i45.6635.
5
Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population.UGT1A1*28*28基因型与日本人群肺癌之间的关联。
Int J Clin Oncol. 2017 Apr;22(2):269-273. doi: 10.1007/s10147-016-1061-2. Epub 2016 Nov 10.
6
[Relationship between UGT1A1 gene polymorphisms and irinotecan-induced severe adverse events].UGT1A1基因多态性与伊立替康所致严重不良事件的关系
Zhonghua Zhong Liu Za Zhi. 2018 Aug 23;40(8):594-599. doi: 10.3760/cma.j.issn.0253-3766.2018.08.006.
7
[Detection of UGT1A1*28 Polymorphism Using Fragment Analysis].[采用片段分析检测UGT1A1*28多态性]
Zhongguo Fei Ai Za Zhi. 2017 Dec 20;20(12):817-821. doi: 10.3779/j.issn.1009-3419.2017.12.04.
8
Correlations of UGT1A1 gene polymorphisms with onset and prognosis of non-small cell lung cancer.UGT1A1 基因多态性与非小细胞肺癌发病及预后的相关性。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):9973-9980. doi: 10.26355/eurrev_202010_23210.
9
The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.UGT1A1*28基因多态性在转移性结直肠癌患者中对伊立替康药效学和药代动力学的影响
J Clin Oncol. 2006 Jul 1;24(19):3061-8. doi: 10.1200/JCO.2005.05.5400.
10
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma.UGT1A1*28基因多态性可预测伊立替康诱导的严重毒性反应,且不影响转移性结直肠癌患者的治疗效果及生存率。
Cancer. 2008 May 1;112(9):1932-40. doi: 10.1002/cncr.23370.

引用本文的文献

1
Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders.代谢、转运体和致病基因对神经疾病中药物遗传学和DNA甲基化的影响。
Biology (Basel). 2023 Aug 22;12(9):1156. doi: 10.3390/biology12091156.
2
Genetic Polymorphisms of ACE1 Rs4646994 Associated with Lung Cancer in Patients with Pulmonary Nodules: A Case-Control Study.血管紧张素转换酶1基因(ACE1)Rs4646994多态性与肺结节患者肺癌的相关性:一项病例对照研究
Biomedicines. 2023 May 26;11(6):1549. doi: 10.3390/biomedicines11061549.

本文引用的文献

1
Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden.肺癌的遗传分析与胚系对体细胞突变负担的影响。
J Natl Cancer Inst. 2022 Aug 8;114(8):1159-1166. doi: 10.1093/jnci/djac087.
2
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women.肺癌中性别差异的演变格局:女性特有的疾病。
Eur Respir Rev. 2022 Jan 12;31(163). doi: 10.1183/16000617.0100-2021. Print 2022 Mar 31.
3
Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy.非小细胞肺癌的现状:流行病学、组织学分类、靶向治疗和免疫治疗
Cancers (Basel). 2021 Sep 20;13(18):4705. doi: 10.3390/cancers13184705.
4
A comprehensive meta-analysis and a case-control study give insights into genetic susceptibility of lung cancer and subgroups.一项综合荟萃分析和病例对照研究深入探讨了肺癌及其亚组的遗传易感性。
Sci Rep. 2021 Jul 16;11(1):14572. doi: 10.1038/s41598-021-92275-z.
5
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.基于证据的个体化医学中评估药物基因组学知识的框架。
Clin Pharmacol Ther. 2021 Sep;110(3):563-572. doi: 10.1002/cpt.2350. Epub 2021 Jul 22.
6
Impact of COL6A4P2 gene polymorphisms on the risk of lung cancer: A case-control study.COL6A4P2 基因多态性对肺癌风险的影响:一项病例对照研究。
PLoS One. 2021 May 21;16(5):e0252082. doi: 10.1371/journal.pone.0252082. eCollection 2021.
7
Epidemiology of lung cancer.肺癌流行病学
Contemp Oncol (Pozn). 2021;25(1):45-52. doi: 10.5114/wo.2021.103829. Epub 2021 Feb 23.
8
Association between NEAT1 polymorphism and the risk of lung cancer: A protocol for systematic review and meta-analysis.NEAT1 多态性与肺癌风险的关联:系统评价和荟萃分析的方案。
Medicine (Baltimore). 2021 Apr 23;100(16):e25478. doi: 10.1097/MD.0000000000025478.
9
Single nucleotide polymorphisms in breast cancer susceptibility gene 1 are associated with susceptibility to lung cancer.乳腺癌易感基因1中的单核苷酸多态性与肺癌易感性相关。
Oncol Lett. 2021 May;21(5):424. doi: 10.3892/ol.2021.12685. Epub 2021 Mar 29.
10
The aging lung: Physiology, disease, and immunity.衰老的肺:生理学、疾病与免疫。
Cell. 2021 Apr 15;184(8):1990-2019. doi: 10.1016/j.cell.2021.03.005. Epub 2021 Apr 2.